Related Experiment Video
Updated: Aug 8, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from
K S Kilgore1, C M Flory, B F Miller
1Department of Pathology, University of Michigan Medical School, Ann Arbor, USA.
Insights
The membrane attack complex (MAC) triggers human umbilical vein endothelial cells (HUVECs) to release neutrophil and monocyte chemokines. Interleukin-8 (IL-8) and MCP-1 are key chemokines involved in this complement-driven cell activation.
Area of Science:
- Immunology
- Cell Biology
- Complement System
Background:
- The membrane attack complex (MAC) is a key component of the complement system.
- MAC assembly on cell surfaces can lead to cell lysis or activation.
- Endothelial cell activation by MAC is relevant to inflammatory conditions like ischemia-reperfusion injury.
Purpose of the Study:
- To investigate the capacity of sublytic MAC concentrations to induce chemokine secretion from human umbilical vein endothelial cells (HUVECs).
- To identify the specific chemokines involved in MAC-induced endothelial cell activation.
Main Methods:
- Exposure of HUVECs to sublytic concentrations of MAC.
- Analysis of conditioned medium for chemotactic activities using enzyme-linked immunosorbent assays (ELISAs).
- Northern hybridization to assess changes in chemokine mRNA levels.
Main Results:
- Sublytic MAC assembly on HUVECs induced sequential secretion of neutrophil and monocyte chemotactic activities.
- Neutrophil chemotaxis was primarily mediated by interleukin-8 (IL-8).
- Monocyte chemotaxis was primarily mediated by MCP-1, with a later peak response.
Conclusions:
- Sublytic MAC assembly on HUVECs triggers a sequential release of IL-8 and MCP-1.
- This process leads to the recruitment of neutrophils and monocytes, contributing to inflammatory responses.
- MAC-induced endothelial cell activation plays a role in complement-mediated inflammatory diseases.
Abstract:
Cell surface assembly of the membrane attack complex (MAC) of complement occurs in a variety of pathophysiological settings. Depending upon the density and size distribution of pores formed by the MAC and the functional integrity of membrane regulators of complement activation, the MAC can either cause direct cell lysis or transduce cell activation. We have examined the functional capacity of sublytic concentrations of MAC to induce the secretion of specific alpha- and beta-chemokines from human umbilical vein endothelial cells (HUVECs). Endothelial cell activation by the MAC has particular relevance to complement-dependent inflammatory processes including ischemia-reperfusion injury and acute lung injury. Assembly of sublytic concentrations of the MAC on HUVECs resulted in the sequential secretion of both neutrophil and monocyte chemotactic activities. Analysis of conditioned medium from MAC-bearing HUVECs revealed that the neutrophil chemotactic activity was largely attributable to interleukin (IL)-8, whereas the monocyte chemotactic activity, which was detected later (peak at 8 hours versus 4 hours), was largely attributable to MCP-1. This temporal pattern of MAC-induced secretion of IL-8 and MCP-1 was confirmed using IL-8- and MCP-1-specific enzyme-linked immunosorbent assays. Northern hybridization analysis of HUVECs revealed that MAC deposition was accompanied by an increase in IL-8 and MCP-1 mRNA levels. These data indicate that assembly of sublytic concentrations of the MAC on HUVECs can induce the sequential secretion of both neutrophil and monocyte chemotactic activities and that the former is largely attributable to IL-8 whereas the latter is largely attributable to MCP-1.
Related Concept Videos
Inflammation
Differentiation of Common Myeloid Progenitor Cells
Complement System
Acute Inflammation I: Inflammatory Response
Acute Inflammation II: Cellular Phase
Acute Inflammation III: Local and Systemic Effects

